Position in OGN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,854,163
-$58,018 QoQ
Shares Held
476,488
+17.3% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $55,696,959 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,248 | $18,683,766 | |
| 2 | LLY |
ELI LILLY & Co
|
8,310 | $9,967,264 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
57,007 | $7,202,264 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,433 | $6,609,140 | |
| 5 | NVO |
Novo Nordisk A S
|
86,018 | $4,123,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,615 | $2,685,956 | |
| 7 | AMGN |
Amgen Inc
|
5,281 | $1,912,355 | |
| 8 | GSK |
GSK plc
|
24,289 | $1,273,229 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,854,163 | 476,488 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,912,181 | 406,162 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,999,862 | 187,253 | Shares | Sole | 2025-10-31 | |
| 2024-03-31 | $714,118 | 37,985 | Shares | Sole | 2024-05-10 | |
| 2023-09-30 | $449,606 | 25,899 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $378,088 | 13,537 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $204,445 | 5,853 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||